Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on September 5, 2002; DOI 10.1182/blood-2002-05-1310.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-05-1310v1
101/1/157    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jankowski, M.
Right arrow Articles by Arnout, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jankowski, M.
Right arrow Articles by Arnout, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted May 6, 2002
Accepted July 11, 2002

Thrombogenicity of ß2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically-induced thrombosis model in the hamster

Milosz Jankowski, Ingrid Vreys, Christine Wittevrongel, Doris Boon, Jos Vermylen, Marc F Hoylaerts, and Jef Arnout*

Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium

* Corresponding author; email: jef.arnout{at}med.kuleuven.ac.be.

We previously showed that ß2GPI-dependent lupus anticoagulants (LA) form bivalent antigen-antibody complexes with high affinity for phospholipids; these complexes are responsible for their in vitro anticoagulant effect. We now studied the role of these bivalent complexes in arterial thrombosis in the hamster. Three monoclonal antibodies (Mab) raised against human ß2GPI were selected on the basis of their cross-reactivity with hamster ß2GPI. Two of these, one with LA activity (5H2) and one with only anticardiolipin properties (11E8), were infused at 0 to 10 mg/kg prior to photochemically-induced vessel damage. 5H2 promoted thrombus formation dose-dependently, raising the thrombus size from 6.0 arbitrary units (AU) in controls (n=9) to 65.0 AU in the high dose group (10 mg/kg, n=6, p=0.007). The LA negative Mab 11E8 and Mab 27A8, reactive with human ß2GPI exclusively, did not significantly promote thrombus formation. In a second set of experiments, intact Mab 5H2 was compared to its fragments. Intact Mab 5H2 at 3.3 mg/kg and the equimolar dose of F(ab')2 fragments (2.2 mg/kg), promoted thrombus formation equally well (55.8 AU, n=8 and 62.5 AU, n=7 respectively); Mab 5H2 derived Fab' fragments were inactive. Immunohistochemical analysis showed platelet-rich thrombi, with 5H2 or its F(ab')2 fragments mainly bound to individual platelets. Our results indicate that bivalent immune complex formation plays an important role in the genesis of arterial thrombosis by certain aPL. Cellular activation via the Fc portion of these immune complexes however is not essential, since F(ab')2 fragments of 5H2 still promote thrombus formation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
Z. Romay-Penabad, M. G. Montiel-Manzano, T. Shilagard, E. Papalardo, G. Vargas, A. B. Deora, M. Wang, A. T. Jacovina, E. Garcia-Latorre, E. Reyes-Maldonado, et al.
Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo
Blood, October 1, 2009; 114(14): 3074 - 3083.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. V. Seshan, C.-W. Franzke, P. Redecha, M. Monestier, N. Mackman, and G. Girardi
Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies
Blood, August 20, 2009; 114(8): 1675 - 1683.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
R. Urbanus, R. Derksen, and P. de Groot
Platelets and the antiphospholipid syndrome
Lupus, October 1, 2008; 17(10): 888 - 894.
[Abstract] [PDF]


Home page
LupusHome page
J. Salmon and P. de Groot
Pathogenic role of antiphospholipid antibodies
Lupus, May 1, 2008; 17(5): 405 - 411.
[Abstract] [PDF]


Home page
haematolHome page
A. Membre, D. Wahl, V. Latger-Cannard, J.-P. Max, P. Lacolley, T. Lecompte, and V. Regnault
The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies
Haematologica, April 1, 2008; 93(4): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
Y Ioannou, A Lambrianides, G Cambridge, M J Leandro, J C W Edwards, and D A Isenberg
B cell depletion therapy for patients with systemic lupus erythaematosus results in a significant drop in anticardiolipin antibody titres
Ann Rheum Dis, March 1, 2008; 67(3): 425 - 426.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Giannakopoulos, F. Passam, S. Rahgozar, and S. A. Krilis
Current concepts on the pathogenesis of the antiphospholipid syndrome
Blood, January 15, 2007; 109(2): 422 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Luster, J. He, X. Huang, S. N. Maiti, A. J. Schroit, P. G. de Groot, and P. E. Thorpe
Plasma Protein beta-2-Glycoprotein 1 Mediates Interaction between the Anti-tumor Monoclonal Antibody 3G4 and Anionic Phospholipids on Endothelial Cells
J. Biol. Chem., October 6, 2006; 281(40): 29863 - 29871.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Fischetti, P. Durigutto, V. Pellis, A. Debeus, P. Macor, R. Bulla, F. Bossi, F. Ziller, D. Sblattero, P. Meroni, et al.
Thrombus formation induced by antibodies to {beta}2-glycoprotein I is complement dependent and requires a priming factor
Blood, October 1, 2005; 106(7): 2340 - 2346.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Zhang and K. R. McCrae
Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-{beta}2 glycoprotein I antibodies
Blood, March 1, 2005; 105(5): 1964 - 1969.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. B. de Laat, R. H.W.M. Derksen, R. T. Urbanus, M. Roest, and P. G. de Groot
{beta}2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome
Blood, December 1, 2004; 104(12): 3598 - 3602.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
M. A. Ozturk, I. C. Haznedaroglu, M. Turgut, and H. Goker
Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia
Clinical and Applied Thrombosis/Hemostasis, April 1, 2004; 10(2): 89 - 126.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
B. C. H. Lutters, R. H. W. M. Derksen, W. L. Tekelenburg, P. J. Lenting, J. Arnout, and P. G. de Groot
Dimers of {beta}2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2'
J. Biol. Chem., September 5, 2003; 278(36): 33831 - 33838.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
T. E. Warkentin, W. C. Aird, and J. H. Rand
Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome
Hematology, January 1, 2003; 2003(1): 497 - 519.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020